comprehensive -WSS

comprehensive

author：focus 2025-09-05 08:10:06 - browse：3

Sage Therapeutics, a biotech developing an experimental treatment for postpartum depression, this week trumpeted strong results from a clinical trial, which cheered investors and pushed up its stock price. But outside the lab, the company’s aggressive efforts to raise awareness of postpartum depression have proved divisive.

The campaign’s message: “When it comes to postpartum depression, silence sucks.” It features close-up photos of distressed, tearful women who can’t speak — because they have pacifiers stuck in their mouths.

The images have been plastered on bus stops, buses, conference booths, and on a dedicated website. The ads don’t specifically mention Sage’s drug, which still needs further testing before the company can bring it to the Food and Drug Administration for possible approval. Instead, they urge women to talk “openly and honestly” about postpartum depression. An estimated 600,000 women in the U.S. alone experience symptoms, which range from insomnia and irritability to difficulty bonding with their baby.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
Next article： FDA panel to weigh safety of artificial wombs for preterm births

WSS

Why the quest to eradicate polio has stumbled

Akili changes sales model for its ADHD video game treatment

U.K. agency declines to back Eli Lilly’s Mounjaro for type 2 diabetes

FDA weighs limits of animal data in assessing artificial wombs

Reanimated hearts work just as well for transplants, study finds

Mom launches Girl Scout troop for LGBTQ youth in Texas

leisure time

comprehensive

explore

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

How to fix the rural physician shortage in the U.S.

Malaria cases in Florida and Texas: Here’s what you need to know

Over 1,300 arrested in France in 4th night of protests over fatal police shooting of teen Nahel M.

Medicare details structure of new drug price negotiation program

U.K. agency declines to back Eli Lilly’s Mounjaro for type 2 diabetes

Hepatitis C has a cure — but many Americans still lack access to it

Chamber of Commerce, DOJ clash in court over drug prices

How one medical school became remarkably diverse

Eli Lilly’s Mounjaro succeeds in second weight

Wikipedia

How to fix the rural physician shortage in the U.S.

Fed up with FDA, ALS advocates consider a take

Biden administration plans revamp of organ transplant system

Eli Lilly’s Mounjaro succeeds in second weight

Over 1,300 arrested in France in 4th night of protests over fatal police shooting of teen Nahel M.

Medicare to pay more for cardiac rehab in hospital outpatient clinics

leisure time

focus

knowledge

hotspot